Picture of Bio-UV SA logo

ALTUV — Bio-UV SA News Story

0.000.00%
fr flag iconLast trade - 00:00
IndustrialsAdventurousMicro CapValue Trap

Brief: Bio-UV Group Eyes EUR 32 Mln In Sales And 10% EBITDA In 2020

Dec 7 (Reuters) - Bio-UV Group SA  ALTUV.PA :
    * 2020 A YEAR OF STRONG AND PROFITABLE GROWTH IN CONTEXT OF
AN
UNPRECEDENTED HEALTH CRISIS: EUR 32 MILLION IN SALES (UP 60%)
AND A 10% EXPECTED EBITDA
    * DOUBLE-DIGIT GROWTH IS ON AGENDA IN 2020 FOR LAND DIVISION
AND
SHOWS AN AUSPICIOUS MOMENTUM FOR 2021 FINANCIAL YEAR
    * STATES THAT TURNOVER OF LAND OPERATIONS IN 2020 WILL BE
HIGHER
THAN ANNUAL PLAN ESTABLISHED BEFORE CORONAVIRUS CRISIS
    * CONFIRMATION OF 2024 AMBITION: EUR60 MILLION IN SALES
    * BIO-UV CONFIRMS ITS TARGET OF 10% EBITDA IN 2020, COMPARED
TO
6.9% A YEAR EARLIER

Source text for Eikon:  ID:nACT66388 
Further company coverage:  ALTUV.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Bio-UV SA

See all news